Titan Pharmaceuticals
TTNP
#11013
Rank
NZ$10.71 M
Marketcap
NZ$8.05
Share price
-3.76%
Change (1 day)
18.86%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): NZ-$7.22

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$7.67. In 2023 the company made an earnings per share (EPS) of NZ-$12.95 an increase over its 2022 EPS that were of NZ-$26.54.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$7.22
2023NZ-$12.95-51.22%
2022NZ-$26.54-15.61%
2021NZ-$31.45-81.37%
2020NZ-$168.76-77.52%
2019NZ-$750.86-56.32%
2018NZ-$1,719-59.51%
2017NZ-$4,246-371.81%
2016NZ$1,562-144.35%
2015NZ-$3,522300%
2014NZ-$880.50-121.54%
2013NZ$4,088-151.38%
2012NZ-$7,956-11.54%
2011NZ-$8,994188.89%
2010NZ-$3,113-10%
2009NZ-$3,459
2007NZ-$14,182-2.38%
2006NZ-$14,528-39.13%
2005NZ-$23,868-16.87%
2004NZ-$28,710-22.43%
2003NZ-$37,0124.9%
2002NZ-$35,28361.9%
2001NZ-$21,792-13.7%
2000NZ-$25,25165.01%
1999NZ-$15,303-35.87%
1998NZ-$23,864-1824.71%
1997NZ$1,384-102.4%
1996NZ-$57,767

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.26-298.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.26-259.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
NZ-$7.08-7.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$1.61-120.96%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
NZ-$0.42-94.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$7.44-2.96%๐Ÿ‡บ๐Ÿ‡ธ USA